
RMTI
Rockwell Medical Inc.
$1.71
-$0.09(-5.00%)
37
Overall
--
Value
18
Tech
57
Quality
Market Cap
$42.69M
Volume
7.70M
52W Range
$0.78 - $5.15
Target Price
$4.00
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $55.4M | $53.3M | $57.3M | $63.4M | $61.3M | $62.2M | $61.9M | $72.8M | $83.6M | $101.5M | ||
Total Revenue | $55.4M | $53.3M | $57.3M | $63.4M | $61.3M | $62.2M | $61.9M | $72.8M | $83.6M | $101.5M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $-46.4M | $-46.5M | $-53.6M | $-65.0M | $58.5M | $59.5M | $64.4M | $68.7M | $74.9M | $84.0M | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $8.9M | $6.8M | $3.7M | $-1.6M | $-58.5M | $2.7M | $-2.4M | $4.1M | $8.7M | $17.5M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $24.0M | $27.0M | $29.6M | $29.8M | $36.9M | $31.2M | $27.9M | $20.9M | $15.4M | $16.9M | ||
Research & Development | $5.0M | $5.8M | $6.3M | $6.7M | $6.9M | $7.1M | $6.8M | $3.1M | $1.1M | $19.0K | ||
Research Expense | $5.0M | $5.8M | $6.3M | $6.7M | $6.9M | $7.1M | $6.8M | $3.1M | $1.1M | $19.0K | ||
Selling, General & Administrative | $19.1M | $21.1M | $23.3M | $23.1M | $30.0M | $24.1M | $21.1M | $17.7M | $14.3M | $16.9M | ||
Selling & Marketing Expenses | $19.1M | $21.1M | $23.3M | $1.0M | $9.1M | $7.9M | $5.7M | $2.1M | $2.1M | $2.7M | ||
General & Administrative Expenses | $-2.3M | $-2.4M | $-2.5M | $22.1M | $21.0M | $16.2M | $15.3M | $15.6M | $12.1M | $14.1M | ||
Salaries & Wages | -- | -- | $-7.2M | $-4.4M | $-5.0M | -- | -- | -- | -- | $1.3M | ||
Depreciation & Amortization | $-655.3K | $-601.1K | $-514.0K | $-649.8K | $-788.0K | $834.0K | $668.0K | $600.0K | $1.2M | $1.6M | ||
Depreciation & Amortization | $-655.3K | $-601.1K | $-514.0K | $-649.8K | $-788.0K | $834.0K | $668.0K | $600.0K | -- | $1.6M | ||
Amortization | -- | -- | -- | -- | -- | $918.0K | $1.2M | $565.0K | $1.5M | $1.5M | ||
Other Operating Expenses | -- | -- | -- | -- | $-2.1M | $2.1M | $2.6M | $2.9M | -- | $2.8M | ||
OPERATING INCOME | ||||||||||||
Operating income | $-15.1M | $-20.2M | $-83.2M | $-94.8M | $-95.4M | $-28.4M | $-30.3M | $-16.8M | $-6.7M | $608.0K | ||
EBITDA | $-13.6M | $-18.6M | $-25.4M | $-31.4M | $-31.4M | $-26.7M | $-27.8M | $-16.2M | $-1.6M | $4.2M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | -- | -- | -- | -- | $25.0K | $1.9M | $2.4M | $1.9M | $2.3M | $114.0K | ||
Intinc | -- | -- | -- | -- | $392.0K | $238.0K | $22.0K | $33.0K | $211.0K | -- | ||
Net Non-Operating Interest Income/Expense | -- | $810.3K | $892 | -- | $367.0K | $-1.6M | $-2.3M | $-1.9M | $-147.0K | $-114.0K | ||
Gain on Sale of Securities | $985.4K | $183.3K | $65.9K | $-222.3K | $30.0K | $8.0K | -- | $4.0K | $532.0K | $192.0K | ||
Other Income/Expense | $-681.9K | $-183.3K | $-56.5M | $-63.2M | $-61.3M | $829.0K | $-1.9M | $4.0K | $-532.0K | $-192.0K | ||
Other Special Charges | $681.9K | $810.3K | $56.5M | $63.4M | $61.3M | $-837.0K | $1.9M | $2.5M | -- | $46.0K | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-1.0M | ||
Special Income Charges | -- | -- | -- | $-1.0M | $-400.0K | -- | -- | -- | $284.0K | $1.0M | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $-14.4M | $-19.4M | $-25.9M | $-32.1M | $-34.1M | $-29.0M | $-30.3M | $-16.7M | $-6.1M | $-366.0K | ||
Pre-Tax Income | $-14.4M | $-19.4M | $-25.9M | $-32.1M | $-34.1M | $-30.9M | $-32.6M | $-18.7M | $-8.4M | $-480.0K | ||
INCOME TAX | ||||||||||||
Tax Provision | -- | $404.5K | -- | -- | -- | -- | -- | -- | -- | -- | ||
NET INCOME | ||||||||||||
Net Income | $-14.4M | $-19.8M | $-25.9M | $-32.1M | $-34.1M | $-30.9M | $-32.7M | $-18.7M | $-8.4M | $-480.0K | ||
Net Income (Continuing Operations) | $-14.4M | $-19.8M | $-25.9M | $-32.1M | $-34.1M | $-30.9M | $-32.7M | $-18.7M | $-8.4M | $-480.0K | ||
Net Income (Discontinued Operations) | $-14.4M | $-19.8M | $-25.9M | $-32.1M | $-34.1M | $-30.9M | $-32.7M | $-18.7M | $-8.4M | $-480.0K | ||
Net Income (Common Stockholders) | $-14.4M | $-19.8M | $-25.9M | $-32.1M | $-34.1M | $-30.9M | $-32.7M | $-18.7M | $-8.6M | $-782.0K | ||
Normalized Income | -- | -- | -- | -- | -- | -- | $-25.8M | -- | -- | $-219.0K | ||
TOTALS | ||||||||||||
Total Expenses | $-22.4M | $-19.6M | $-24.0M | $-35.2M | $95.4M | $90.6M | $92.2M | $89.6M | $90.3M | $100.9M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $4.6M | $4.6M | $4.6M | $4.8M | $5.5M | $6.9M | $8.5M | $9.9M | $23.3M | $31.1M | ||
Average Shares Outstanding (Diluted) | $4.6M | $4.6M | $4.6M | $4.8M | $5.5M | $6.9M | $8.5M | $9.9M | $23.3M | $31.1M | ||
Shares Outstanding | $4.7M | $4.7M | $4.7M | $5.2M | $6.3M | $8.5M | $8.5M | $12.6M | $29.3M | $34.1M | ||
Basic EPS | -- | $-4.29 | $-5.61 | -- | -- | $-4.51 | $-3.85 | $-1.89 | $-0.37 | $-0.03 | ||
Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-4.51 | $-3.85 | $-1.89 | $-0.37 | $-0.03 | ||
Diluted EPS | $-3.19 | $-4.29 | $-5.61 | $-6.71 | $-6.16 | $-4.51 | $-3.85 | $-1.89 | $-0.37 | $-0.03 | ||
Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-6.16 | -- | $-3.85 | $-1.89 | $-0.37 | $-0.03 | ||
OTHER METRICS | ||||||||||||
Accretion On Preferred Stock | -- | -- | -- | -- | -- | -- | -- | -- | -- | $302.0K | ||
Fees | $275.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Net Operating Interest Income Expense | -- | -- | $790.2K | $535.6K | -- | -- | -- | -- | -- | -- | ||
Non Recurring Operation Expense | -- | -- | -- | $1.0M | $400.0K | -- | -- | -- | -- | -- | ||
Other Gand A | $-2.3M | $-2.4M | $-2.5M | $22.1M | $21.0M | $16.2M | $15.3M | $15.6M | $12.1M | $14.1M | ||
Otherunder Preferred Stock Dividend | -- | -- | -- | -- | -- | -- | -- | -- | $150.0K | $302.0K | ||
Preferred Stock Dividends | -- | -- | -- | -- | -- | -- | -- | -- | $150.0K | $302.0K | ||
Rent And Landing Fees | $-2.3M | $-2.4M | $-2.5M | $22.1M | -- | -- | -- | -- | -- | -- | ||
Selling Expense | $19.1M | $21.1M | $23.3M | $1.0M | $9.1M | -- | -- | -- | -- | -- | ||
Restruct | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-1.0M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | RMTI | $1.71 | -5.0% | 7.70M |
3 | ||||
4 | ||||
5 | ||||
6 |